Study of Botulinum Toxin and Recovery of Hand Function After Stroke

PHASE3CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Stroke With Hemiparesis
Interventions
DRUG

Botulinum Toxin commonly known as BOTOX®

"A total dose between 200-300 units of Botulinum toxin will be administered across 12 muscles of the affected hand.~There will be 1 treatment cycle during the 9 week study."

DRUG

Placebo

The control group will receive a placebo injection.

Trial Locations (1)

10016

New York University School of Medicine, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

NYU Langone Health

OTHER